WATSON 782 (Diethylpropion Extended-Release 75 mg)
Pill imprint WATSON 782 has been identified as Diethylpropion hydrochloride extended-release 75 mg.
Diethylpropion is used in the treatment of obesity and belongs to the drug classes anorexiants, CNS stimulants. There is no proven risk in humans during pregnancy. Diethylpropion 75 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
See also related documents.
Images for WATSON 782 (Diethylpropion Extended-Release 75 mg)
- 75 mg
- 19.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- 4 - Some potential for abuse
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- carbomer 934
|NDC Code||Manufacturer / Repackager|
|54569-0396||A S Medication Solutions LLC (repackager)|
|54868-1463||Physicians Total Care Inc (repackager)|
|66336-0689||Dispensing Solutions Inc. (repackager)|
|23490-5435||Palmetto State Pharmaceuticals Inc (repackager)|
|49999-0457||Lake Erie Medical and Surgical Supply (repackager)|
|21695-0876||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.
Diethylpropion hydrochloride extended-release is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...